News
The Latest
Transmission of Human Herpes Virus Type 8 (HHV-8, The Kaposi's Sarcoma-Associated Herpes Virus)
Although it has been over five years since the initial reports of a virus related to KS were made, it is still unclear just how this virus is transmitted. Studies by various investigators have shown a clear and fairly striking relationship between th...
Prior Pneumonia, Smoking, and Drinking Explain Higher Lung Cancer Risk With HIV
A past pneumonia episode largely explained a higher risk of lung cancer in people living with HIV, according to a large study in California. Smoking and alcohol abuse also contributed to the higher risk.
Starting HIV Treatment Early Reduces HIV-Related Cancer Risk by 74%
Starting HIV treatment soon after diagnosis may reduce the risk of developing HIV-related cancer by 74%, according to a recent study.
What Women With HIV Should Know About Menstruation and Aging
Introduction
The Menstrual Cycle
Menstrual Irregularities in Women with HIV
Menopause
HIV and Menopause
Osteopenia and Osteoporosis
Cardiovascular Risk
Management of Menopause
Symptom Management
Avoiding Long-Term Complicat...New Hope: AIDS Malignancy Consortium Offers New Hope to People With AIDS-Related Cancer
Following is Part I of a two-part interview with Dr. David Aboulafia, a leading Northwest oncologist in the field of AIDS-related cancer. Dr. Aboulafia, who heads the AIDS Malignancy Consortium, presented a two-hour community meeting on AIDS-related ...
ACTG Oncology Committee Finds New Home at National Cancer Institute, But Funding Is Woefully Inadequate
After eight, long, hard years of work with the ACTG and Division of AIDS (DAIDS), the Oncology Committee was finally pushed out during the AIDS Clinical Trials Group (ACTG)'s recent recompetition. They have been told that no new Kaposi's sarcoma (KS)...
New Anti-HIV Vaccine and KS Trials at the National Cancer Institute
The Adult Clinical AIDS Program in the National Cancer Institute is presently recruiting for the following clinical trials for HIV infection and Kaposi's sarcoma (KS). Dr. Robert Yarchoan is the Principal Investigator for these trials:
Protocols for...